Skip to Content

University researchers helped the Vercise Deep Brain Stimulation System for Parkinson's treatment reach FDA approval.

Led by neurology department chairman Dr. Jerrold Vitek and backed by the state-funded MnDRIVE research program, the U of M Medical School played a key role in the multi-site “INTREPID” clinical study, which was completed shortly before the FDA decision.

The full story was published in Twin Cities Business in January 2018.

Announcements for the UMN Research Community